Why is the ResApp share price lifting today?

Progress on a takeover bid for the company has been announced.

| More on:
A group of people in a corporate setting do a collective high five.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Shareholders have given the green light on a takeover proposal from Pfizer
  • The court must approve it for the deal to proceed
  • The deal is expected to close on the 23rd of September

The ResApp Health Ltd (ASX: RAP) share price is in the green today as investors digest the latest news on Pfizer's proposed takeover bid.

Shares in the ASX healthcare company are up 0.98%, trading at 21 cents at the time of writing after shareholders yesterday approved the scheme of arrangement for Pfizer to acquire 100% of ResApp's shares.

ResMed advised the next step of the takeover process would involve a second court hearing at the Supreme Court of New South Wales to be held on Tuesday next week.

For the bid to be accepted, the Supreme Court must first approve it on the condition that it's in the best interest of ResApp shareholders. Also, any remaining conditions must be either satisfied or waived before the hearing.

If these conditions are met, the deal is expected to complete on 23 September. The last date that ResApp shares will trade on the ASX will be Wednesday, 14 September.

Pfizer upgraded its bid to 20.8 cents per share on Saturday last week, up from 14.6 cents per share.

That puts ResApp's valuation in the $198.8 million ballpark at the time of writing.

ResApp share price snapshot

The ResApp share price is up a stunning 195.7% year to date. Meanwhile, the S&P/ASX 200 Index (ASX: XJO) is down 10.77% over the same period.

The company's market capitalisation is $178.3 million at the time of writing.

Motley Fool contributor Matthew Farley has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »

A young man goes over his finances and investment portfolio at home.
Healthcare Shares

Down 20%, is the NIB share price undervalued?

Here's what Goldman Sachs is saying about this blue chip stock.

Read more »

four excited doctors with their hands in the air
Healthcare Shares

Sigma Healthcare shares rocket 39% on Chemist Warehouse merger approval

The ACCC doesn't believe the company's merger with Chemist Warehouse will lessen competition.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

ASX 200 healthcare stock rockets on $75 million news

This marks another positive step for the company.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

CSL shares are in the red for 2024. Are they a buy?

Meanwhile, the broader market has extended to new highs this year.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Share Market News

Guess which ASX 300 stock is jumping 11% on big news

Big news is giving this stock an even bigger lift on Tuesday. What's happening?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 200 healthcare stock is starting the week with a bang on big news!

What is getting investors excited today? Let's find out.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »